Pharmacological interventions for self‐harm in adults
Cochrane authors have reviewed the international literature regarding pharmacological (drug) and natural product (dietary supplementation) treatment trials in the field. A total of seven trials that met inclusion criteria were identified. There is little evidence of beneficial effects of either...
14 Siječanj 2021
What is the best way to support resilience and mental well-being in frontline healthcare professionals during and after a pandemic? What is ‘resilience’?
Updated Jan 2021: Listen to lead author Alex Pollock from Glasgow Caledonian University in Scotland explain what the review found.
Updated Dec 2020: new brief for health systems planners and...
8 Siječanj 2021
In this short interview, PhD student Camilla Hansen Nejstgaard, from Cochrane Denmark and Centre for Evidence-Based Medicine Odense (CEBMO) at the University of Southern Denmark, tells us about how conflicts of interest may impact on recommendations of drugs and medical devices. She is the lead author of a recently published Cochrane Methodology...
5 Siječanj 2021
Rebecca Selby, a mum of four, shares how a Cochrane Review impacted her family.
When I unexpectedly went into premature labour with our second son at a little under 32 weeks' gestation, I was given steroid injections to give his lungs the best possible chance in the outside world. George spent almost a month in intensive care when he was born,...
29 Prosinac 2020
Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews
A stillbirth is generally defined as the death of a baby before birth, at or after 24 weeks of development. It is most common in low‐ and middle‐income countries but also affects people in high‐income countries. Numbers of...
23 Prosinac 2020
Cochrane has expanded its response to COVID-19 by publishing two rapid scoping reviews about care bundles in the intensive care unit (ICU) and measures implemented in schools to contain the SARS-CoV-2 virus. Both reviews were commissioned by the World Health Organisation to inform their guidance. The reviews serve as exemplars for how similar...
22 Prosinac 2020
Read this recently published Cochrane review about CFTR correctors, a therapy for cystic fibrosis targeted at specific variants (most commonly F508del)
In this review, the authors looked at drugs (or drug combinations) for correcting the basic defect in the most common cystic fibrosis (CF)-causing gene variant (F508del) and assessed their impact...
17 Prosinac 2020
Interventions to reduce tobacco use in people experiencing homelessness
BackgroundPeople experiencing homelessness are more likely to use tobacco, and face many problems that make it difficult for them to quit. Health problems caused by using tobacco are among the leading causes of death among this group of people, so there is a need to find new...
10 Prosinac 2020
New Cochrane Systematic Review shows that knee replacement surgery using a tourniquet increases the risk of serious complications, and causes additional pain after surgery
What are the benefits and risks of using a tourniquet in knee replacement surgery? Senior author Mr Peter Wall, Consultant Orthopaedic Surgeon from Warwick Clinical Trials Unit...
9 Prosinac 2020
Interventions to increase patient and family involvement in escalation of care for acute life‐threatening illness in community health and hospital settings
Medical emergenciesA life‐threatening condition is a medical emergency. The faster a person secures the right medical care, the better their chances of surviving. When patients and their...
9 Prosinac 2020